Xtrackers S&P Europe ex UK UCITS ETF 1D (GBP) | XUEKRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.4 | 25.3 | -12.9 | 18.4 | 5.1 | |
+/-Cat | -7.0 | 9.9 | -4.2 | 4.9 | 0.5 | |
+/-B’mrk | -5.5 | 8.1 | -5.5 | 3.4 | 0.4 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
Closing Price 06/05/2024 | GBX 6092.00 | |
Day Change | 0.83% | |
Morningstar Category™ | Europe ex-UK Equity | |
Volume | 16997 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BGV5VM45 | |
Fund Size (Mil) 03/05/2024 | EUR 503.87 | |
Share Class Size (Mil) 03/05/2024 | EUR 503.87 | |
Ongoing Charge 22/06/2023 | 0.09% |
Investment Objective: Xtrackers S&P Europe ex UK UCITS ETF 1D (GBP) | XUEK |
The investment objective of the Fund is to track the performance before fees and expenses of the Underlying Asset, which is the S&P Europe Ex-U.K. LargeMidCap (EUR) Index (the "Reference Index"). The Reference Index is designed to reflect the performance of shares of large- and mid-cap constituents of the S&P Europe BMI (the "Parent Index"), excluding the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 14/01/2019 | ||
Inception Date 14/01/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Europe Ex-U.K. LargeMidCap EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Xtrackers S&P Europe ex UK UCITS ETF 1D (GBP) | XUEK | 06/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.80 |
ASML Holding NV | Technology | 4.36 |
Nestle SA | Consumer Defensive | 3.28 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.66 |
Novartis AG Registered Shares | Healthcare | 2.44 |
Increase Decrease New since last portfolio | ||
Xtrackers S&P Europe ex UK UCITS ETF 1D (GBP) | XUEK |